Granules India Ltd

Granules India Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Granules India Ltd has witnessed a notable change in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle yet significant shift in price attractiveness. This development comes amid robust stock performance and evolving market dynamics within the Pharmaceuticals & Biotechnology sector.

Granules India Limited, a vertically integrated pharmaceutical manufacturer specialising in active pharmaceutical ingredients (APIs) and finished dosages, reported mixed results for Q1 FY27, with net profit declining 10.72% quarter-on-quarter to ₹179.96 crores despite achieving record quarterly revenues. The Hyderabad-based company, commanding a market capitalisation of ₹22,001 crores, saw its stock trade at ₹875.45 on July 21, down marginally by 0.06% from the previous close, reflecting investor concerns over profitability compression even as topline momentum remained robust.

Surging to a fresh 52-week and all-time high of Rs 907 on 16 Jul 2026, Granules India Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market with an 81.19% gain over the past year against the Sensex’s decline of 6.43%.

Extending its impressive rally, Granules India Ltd touched a fresh all-time high of Rs 907 on 16 Jul 2026, outpacing the broader Sensex which gained a modest 0.20% on the day. This milestone caps a remarkable run where the stock has surged over 80% in the past year, significantly outperforming its sector and the benchmark indices.

Granules India Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Surging past the Rs 900 mark for the first time, Granules India Ltd has reached a new 52-week high of Rs 907 on 13 Jul 2026, marking a remarkable 92.11% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength, even as the broader Sensex trades lower.

Extending its winning streak to three sessions, Granules India Ltd surged to a fresh all-time high of Rs 907 on 13 Jul 2026, outpacing the broader Sensex which declined by 0.80% on the day. This rally adds to an impressive 92.18% return over the past year, underscoring the stock’s strong momentum across multiple timeframes.

Surging to an all-time high of Rs 899 on 10 Jul 2026, Granules India Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with an 89.05% gain over the past year. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust trading volumes.

Extending its recent rally, Granules India Ltd touched a fresh all-time high of Rs 896.55 on 10 Jul 2026, marking a significant milestone in its price journey. This surge comes amid sustained outperformance against the broader market and sector indices, reflecting strong momentum across multiple timeframes.

Granules India Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting a significant change in price attractiveness. This development comes amid robust stock performance and evolving market dynamics within the Pharmaceuticals & Biotechnology sector.

With a decisive surge to an intraday high of Rs 897.4 on 9 Jul 2026, Granules India Ltd has reached a fresh 52-week and all-time high, extending its remarkable 84.78% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance against the broader market indices.

Extending its impressive rally, Granules India Ltd touched a fresh all-time high of Rs 878 on 09 Jul 2026, marking a significant milestone in its market journey amid broad-based bullish momentum.

Surging to an all-time high of Rs 878 on 7 Jul 2026, Granules India Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 7.81% gain over the past four trading sessions. This milestone caps a year-long rally that has seen the stock appreciate by 77.48%, vastly outpacing the Sensex’s decline of 6.09% during the same period.

Extending its winning streak to four consecutive sessions, Granules India Ltd surged 2.21% today to touch a fresh all-time high of Rs 872, significantly outpacing the Sensex which inched up just 0.09%. This rally adds to a remarkable 7.24% gain over the past four days, underscoring strong momentum across multiple timeframes.

Surging to an all-time high of Rs 865 on 6 Jul 2026, Granules India Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 72.64% gain over the past year. This milestone reflects a confluence of strong technical signals and sustained buying interest that has propelled the stock well above its 52-week low of Rs 433.

Granules India Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 6 July 2026, with its stock price touching an all-time high of Rs.848. This achievement reflects the company’s sustained strong performance and robust financial health amid a volatile market environment.